Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.5 was added to the Record History, and the previous revision v3.6.4 was removed, indicating a software update reflected in the page history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history now shows a new site revision entry (v3.6.4) replacing the previous (v3.6.3) in the page’s revision log.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history shows a new revision entry for v3.6.3 was added, replacing the previous v3.6.2, indicating a system update to the page's history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry (v3.6.2) has been added to the study record history, and the previous revision (v3.6.0) has been removed. This update updates the historical log for the ClinicalTrials.gov record rather than changes to the study data.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record now shows that recruitment is not currently accepting participants, indicating the trial is not seeking new subjects. A new revision (v3.6.0) was added and the previous revision (v3.5.5) was removed.SummaryDifference0.4%

- Check65 days agoChange DetectedA new Revision: v3.5.5 appears in the record history, signaling a recent update to the study record; the previous Revision: v3.5.4 entry seems to be removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.